Efficacy and safety of high Ginsenoside F1 extract on improvement of Cognitive Functio

Not Applicable

Recruiting

• Conditions: Diseases of the nervous system

• Registration Number: KCT0005509
• Lead Sponsor: Jeonbuk National University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2021-08-09
• Last Update Posted: 5 October 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

1) Males and females aged 60 years over at the screening examination
2) Participants who have mini mental state examination score of 25 to 28.
3) Participants who have fully understand the information provided about the study voluntarily decided to participate and agree to comply with precautions.

Exclusion Criteria

1) The patients who have a history of alcoholism or drug dependency/abuse within the last 3 months before the screening examination.
2) The patients who take medicine, health functional foods or oriental medicine within the last 1 month before the screening examination.
3) Patients who have participated in other clinical trials within the last 3 months before the screening examination.
4) Patients who have laboratory test outcomes as follow.
? AST(Aspartate aminotransferase), ALT(Alanine Transaminase) > three times the normal limit
? Serum Creatinine > 2.0 mg/dL
5) Patients who are judged ineligible to participate in the trial by the principal investigator for other reasons, including laboratory test outcomes.

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cognitive Function Test

Secondary Outcome Measures

Name	Time	Method
Korean Version of the Montreal Cognitive Assessment;Perceived stress scale;Beck Depression Inventory;Brain-derived neurotrophic factor;Amyloid ß